Amarin reported $227.61M in Stock for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Stock Change
Alnylam Pharmaceuticals ALNY:US USD 115.49M 26.51M
Amarin AMRN:US USD 227.61M 1.83M
Esperion Therapeutics ESPR:US USD 29.54M 313K
GlaxoSmithKline GSK:LN GBP 5.15B 487M
Halozyme Therapeutics HALO:US USD 103.28M 5.66M
Heron Therapeutics HRTX:US USD 52.24M 9.08M
IONIS PHARMACEUT IONS:US USD 20.64M 834K
JAZZ PHA JAZZ:US USD 728.07M 133.63M
Nektar Therapeutics NKTR:US USD 19.06M 2.09M
Novartis NOVN:VX USD 7.18B 396M
Teva Pharmaceutical Industries TEVA:US USD 3.86B 190M